Glomerulonephritis, Membranous: all 146 studies
Page 2 of 2. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Obinutuzumab in Primary MNCompletedNCT05050214Phase 2
- MOR202 for Refractory MNCompletedNCT04893096Phase 2
- Causes and Prevention of Thromboembolic Disease in Nephrotic SyndromeCompletedNCT04850378Phase 1/2
- Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMNTerminatedNCT04743739Phase 3
- Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)CompletedNCT04733040Phase 2
- Efficacy and Safety of VB119 in Subjects With Membranous NephropathyTerminatedNCT04652570Phase 1/2
- A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous NephropathyActive, not recruitingNCT04629248Phase 3
- The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket TrialStatus unknownNCT04498962Not applicable
- Global Kidney Patient Trials NetworkCompletedNCT04389827
- A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic SyndromeCompletedNCT04278729Phase 1
- Rituximab in Refractory Primary Membranous NephropathyCompletedNCT03880643
- Tacrolimus Monotherapy for Idiopathic Membranous NephropathyStatus unknownNCT03864250Not applicable
- Personalized Medicine for Membranous NephropathyCompletedNCT03804359Phase 2
- Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)Status unknownNCT03549663Not applicable
- Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous NephropathyTerminatedNCT03475602
- The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.TerminatedNCT03466801Not applicable
- Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous NephropathyCompletedNCT03255447Not applicable
- Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous NephropathyStatus unknownNCT03170323Phase 4
- Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)Status unknownNCT03062813Phase 4
- Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous NephropathyStatus unknownNCT03018535Phase 3
- Study on the Therapeutic Effect of TCM Treatment for MDR MNStatus unknownNCT02610595Not applicable
- Role of Anti-mouse PLA2R1 ELISA in Membranous NephropathyCompletedNCT02199145Not applicable
- A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous NephropathyStatus unknownNCT02173106Phase 2
- Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous NephropathyCompletedNCT01955187Phase 3
- Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous NephropathyCompletedNCT01845688Not applicable
- Vitamin D Supplementation in Glomerular DiseaseCompletedNCT01835639Not applicable
- Study on Single-nucleotide-polymorphism in Idiopathic Membranous NephropathyStatus unknownNCT01799460
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous NephropathyWithdrawnNCT01762852Phase 2
- Evaluate Rituximab Treatment for Idiopathic Membranous NephropathyCompletedNCT01508468Phase 3
- Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus SteroidCompletedNCT01161459Not applicable
- Aliskiren in Patients With Idiopathic Membranous NephropathyWithdrawnNCT01093781Not applicable
- The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous NephropathyCompletedNCT00983034Not applicable
- Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous NephropathyCompletedNCT00805753Phase 1
- Treatment With Synthetic ACTH in High Risk Patients With Membranous NephropathyCompletedNCT00694863Phase 2
- To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)CompletedNCT00518219Phase 4
- Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus ErythematosusTerminatedNCT00479622Phase 1
- Rituximab in Membranous NephropathyCompletedNCT00425217Phase 2/3
- Rituximab in the Treatment of Idiopathic Membranous NephropathyCompletedNCT00405340Early Phase 1
- Mycophenolate Mofetil in Membranous Nephropathy and Focal SegmentalCompletedNCT00404833Phase 3
- A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus NephritisCompletedNCT00404794Phase 3
- Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic SyndromeCompletedNCT00362531Phase 2/3
- Tacrolimus Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00302523Not applicable
- Research Network for Neonatal Diseases Induced by Tissular Fetomaternal AlloimmunizationCompletedNCT00199628
- Mycophenolate Mofetil in Membranous NephropathyCompletedNCT00135967Phase 2/3
- Treatment of Patients With Idiopathic Membranous NephropathyCompletedNCT00135954Phase 3
- Sirolimus Therapy for Idiopathic and Lupus Membranous NephropathyCompletedNCT00050713Phase 2